{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:58Z","timestamp":1787067478933,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.vaccine.2006.03.043","type":"journal-article","created":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T07:14:54Z","timestamp":1143789294000},"page":"4987-4994","source":"Crossref","is-referenced-by-count":34,"title":["Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice"],"prefix":"10.1016","volume":"24","author":[{"given":"Jennifer M.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie E.","family":"Ziman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M.","family":"Moroski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vajdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay V.","family":"Solnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.vaccine.2006.03.043_bib1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.03.043_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.immunol.19.1.523","article-title":"The design of vaccines against Helicobacter pylori and their development","volume":"19","author":"Del Giudice","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.043_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc703","article-title":"Helicobacter pylori and gastrointestinal tract adenocarcinomas","volume":"2","author":"Peek","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.043_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/CMR.9.4.532","article-title":"Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases","volume":"9","author":"Lucey","year":"1996","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2006.03.043_bib5","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1128\/IAI.73.9.5612-5619.2005","article-title":"Helicobacter pylori-specific CD4(+) T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa","volume":"73","author":"Lundgren","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.043_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2249.1998.00662.x","article-title":"Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans","volume":"113","author":"Louis","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.03.043_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1348-0421.2004.tb03474.x","article-title":"Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection","volume":"48","author":"Yamamoto","year":"2004","journal-title":"Microbiol Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.03.043_bib8","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.4049\/jimmunol.169.12.6977","article-title":"Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells","volume":"169","author":"Akhiani","year":"2002","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.043_bib9","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1128\/IAI.71.6.3628-3633.2003","article-title":"Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4","volume":"71","author":"Garhart","year":"2003","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.043_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1286-4579(00)00367-1","article-title":"Helicobacter pylori infection in wild-type and cytokine-deficient C57BL\/6 and BALB\/c mouse mutants","volume":"2","author":"Kamradt","year":"2000","journal-title":"Microb Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2006.03.043_bib11","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.4049\/jimmunol.170.5.2399","article-title":"Memory CD8+ T cells provide an early source of IFN-gamma","volume":"170","author":"Kambayashi","year":"2003","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.043_bib12","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.4049\/jimmunol.173.11.6873","article-title":"Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18","volume":"173","author":"Raue","year":"2004","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.03.043_bib13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/labinvest.3700148","article-title":"Human neutrophils produce interferon gamma upon stimulation by interleukin-12","volume":"84","author":"Ethuin","year":"2004","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.043_bib14","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4049\/jimmunol.172.3.1754","article-title":"Distinct modulatory effects of LPS and CpG on IL-18-dependent IFN-gamma synthesis","volume":"172","author":"Gould","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.03.043_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0147-9571(01)00029-7","article-title":"Study of interleukin-10 and interleukin-12 productions in response to lipopolysaccharides extracted from two different Brucella strains","volume":"25","author":"Kariminia","year":"2002","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.043_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1574-695X.1993.tb00344.x","article-title":"Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria","volume":"6","author":"Birkholz","year":"1993","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.043_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/infdis\/170.1.135","article-title":"Neutrophil activation by Helicobacter pylori lipopolysaccharides","volume":"170","author":"Nielsen","year":"1994","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2006.03.043_bib18","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S0264-410X(97)00102-3","article-title":"Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506)","volume":"15","author":"Ogawa","year":"1997","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.043_bib19","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1128\/IAI.72.7.3925-3931.2004","article-title":"Helicobacter pylori with a truncated lipopolysaccharide O chain fails to induce gastritis in SCID mice injected with splenocytes from wild-type C57BL\/6J mice","volume":"72","author":"Eaton","year":"2004","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.043_bib20","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1128\/IAI.72.11.6446-6454.2004","article-title":"Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4","volume":"72","author":"Mandell","year":"2004","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.043_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cyto.2004.10.013","article-title":"Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome","volume":"29","author":"Zambon","year":"2005","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.vaccine.2006.03.043_bib22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.191.9.1467","article-title":"The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor","volume":"191","author":"Satin","year":"2000","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2006.03.043_bib23","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1128\/IAI.68.5.2775-2782.2000","article-title":"Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection","volume":"68","author":"Weltzin","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.043_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2567.2003.01711.x","article-title":"Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations","volume":"110","author":"Vajdy","year":"2003","journal-title":"Immunology"},{"issue":"21","key":"10.1016\/j.vaccine.2006.03.043_bib25","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.1128\/JVI.77.21.11708-11717.2003","article-title":"Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy","volume":"77","author":"Guadalupe","year":"2003","journal-title":"J Virol"},{"issue":"5396","key":"10.1016\/j.vaccine.2006.03.043_bib26","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.043_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1084\/jem.189.4.615","article-title":"Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)","volume":"189","author":"Qureshi","year":"1999","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.043_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/09680519010070060501","article-title":"Differential clearance and induction of host responses by various administered or released lipopolysaccharides","volume":"7","author":"Hasunuma","year":"2001","journal-title":"J Endotoxin Res"},{"issue":"15","key":"10.1016\/j.vaccine.2006.03.043_bib29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.micinf.2004.08.015","article-title":"Endotoxin recognition and signal transduction by the TLR4\/MD2-complex","volume":"6","author":"Fitzgerald","year":"2004","journal-title":"Microb Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.043_bib30","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1128\/IAI.60.4.1714-1716.1992","article-title":"Low biological activity of Helicobacter pylori lipopolysaccharide","volume":"60","author":"Muotiala","year":"1992","journal-title":"Infect Immun"},{"issue":"20","key":"10.1016\/j.vaccine.2006.03.043_bib31","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/jb.179.20.6453-6463.1997","article-title":"Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides","volume":"179","author":"Moran","year":"1997","journal-title":"J Bacteriol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.043_bib32","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1128\/IAI.66.11.5357-5363.1998","article-title":"Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes","volume":"66","author":"Bliss","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.043_bib33","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1128\/jb.174.4.1370-1377.1992","article-title":"Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides","volume":"174","author":"Moran","year":"1992","journal-title":"J Bacteriol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.03.043_bib34","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/gut.2003.029736","article-title":"Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection","volume":"53","author":"Rad","year":"2004","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.vaccine.2006.03.043_bib35","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/IAI.63.4.1183-1187.1995","article-title":"Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide","volume":"63","author":"Perez-Perez","year":"1995","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.03.043_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1432-1327.2000.01007.x","volume":"267","author":"Monteiro","year":"2000","journal-title":"Eur J Biochem"},{"issue":"6","key":"10.1016\/j.vaccine.2006.03.043_bib37","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/IAI.69.6.3891-3896.2001","article-title":"Effect of purified lipopolysaccharides from strains of Helicobacter pylori and Helicobacter felis on acid secretion in mouse gastric glands in vitro","volume":"69","author":"Padol","year":"2001","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2006.03.043_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.molmed.2004.06.001","article-title":"Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry","volume":"10","author":"D\u2019Elios","year":"2004","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.043_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/jaut.2000.0490","article-title":"Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity","volume":"16","author":"Moran","year":"2001","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.043_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0928-8244(03)00023-3","article-title":"Helicobacter pylori lipopolysaccharide in the IL-2 milieu activates lymphocytes from dyspeptic children","volume":"36","author":"Rudnicka","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.043_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/00365529709000195","article-title":"Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide","volume":"32","author":"Piotrowski","year":"1997","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.03.043_bib42","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/IAI.65.8.3310-3316.1997","article-title":"The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis","volume":"65","author":"Sakagami","year":"1997","journal-title":"Infect Immun"},{"issue":"24","key":"10.1016\/j.vaccine.2006.03.043_bib43","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/S0264-410X(00)00052-9","article-title":"Further development of the Helicobacter pylori mouse vaccination model","volume":"18","author":"Sutton","year":"2000","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2006.03.043_bib44","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1128\/IAI.70.11.6383-6388.2002","article-title":"Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines","volume":"70","author":"Raghavan","year":"2002","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.03.043_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0928-8244(03)00091-9","article-title":"Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens","volume":"36","author":"Keenan","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.03.043_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1523-5378.2005.00293.x","article-title":"Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection","volume":"10","author":"Shi","year":"2005","journal-title":"Helicobacter"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06003495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06003495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T09:06:26Z","timestamp":1586768786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06003495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":46,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0264410X06003495"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.03.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}